2 recruiting, 1 terminated, 1 unknown. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 2, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Terminated 1 |
Follow GVHD,Acute: new trials by email Literature Review of GVHD,Acute trials Research Report on GVHD,Acute
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease ) Ruxolitinib, Corticosteroids - GVHD,Acute, Stem Cell Transplant Complications | Phase 2 | Recruiting | Daihong Liu | 168 | 2025-06-01 | 2026-01-14 |
| Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant ATG Combined with Tacrolimus and Mini Methotrexate - GVHD,Acute, Acute Leukemia | Phase 2 | Recruiting | University of Alabama at Birmingham | 29 | 2025-04-15 | 2026-10-09 |
| MAP-guided Preemptive Therapy of aGvHD Methylprednisolone - GVHD,Acute, Stem Cell Transplant Complications | Phase 2 | Unknown | Sichuan University | 56 | 2022-05-01 | 2022-05-10 |
| A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease Itacitinib, Prednisone, Methylprednisolone - GVHD,Acute | Phase 1 / Phase 2 | Terminated | Innovent Biologics (Suzhou) Co. Ltd. | 1 | 2020-06-18 | 2020-10-29 |
Leukemia (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1)
Bone Marrow Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Methylprednisolone (2) · Adrenal Cortex Hormones (1) · Prednisone (1) · Tacrolimus (1) · itacitinib (1) · ruxolitinib (1)
Daihong Liu (1) · Innovent Biologics (Suzhou) Co. Ltd. (1) · Sichuan University (1) · University of Alabama at Birmingham (1)
China (3) · United States (1)